https://doronscientific.com/wp-content/uploads/2022/12/doron-scintific-logo.png 0 0 firstname.lastname@example.org https://doronscientific.com/wp-content/uploads/2022/12/doron-scintific-logo.png email@example.com 13:47:202023-02-21 13:47:23Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Carrier-free) (recommended for ADA assay) DMF Filed
Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Carrier-free) (recommended for ADA assay) DMF Filed
FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.
Target of Antibodies